Search for Clinical Trials
A study to determine if the combination of avelumab with several different drugs is safe and effective for treating patients with metastatic triple-…
This study is to find out if patients with HER2-positive breast cancer who have no cancer remaining at surgery after 12 weeks of chemotherapy and 2…
This study is being done to find out if tucatinib plus T-DM1 works better to treat breast cancer than T-DM1 alone.
Tucatinib is a type of drug…
The purpose of this study is to compare existing treatment with any effects of receiving 1 year of treatment with pembrolizumab after surgery.
A study to determine if the addition of atezolizumab to chemotherapy improves response in the breast and lymph nodes in patients with triple-negative…
The purpose of this study is to find out if adding simvastatin to dual anti-HER2 treatment can slow down the growth or reduce the size of your…
This study is to see how ruxolitinib changes the breast cells when given to patients with premalignant breast conditions in order to know if it might…
This study is being done to learn more about the safety and effectiveness of an investigational oral medication called ORIN1001 for people with…
M16-067: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects…
RPC-3201: Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for…
